Search results :

Olmesartan

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: None found

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8
Influenza like illness Influenza-like symptoms common, 3% - 3.59% 3.24% x x x x x x x x
Influenza like illness 1.35% - 2.14% 1.93% x
Dizziness Dizziness common, 0% - 3.08% 0% - 3.57% x x x x x x x x
Syncope uncommon x
Lightheadedness x
Headache Headache postmarketing — 0% - 7.53% 0% - 8.65% x x x x x x x x
Abdominal pain Abdominal pain postmarketing, common x x x x x x x x
Gastrointestinal pain Abdominal pain postmarketing, common x x x x x x x x
Haematuria Haematuria common, 1.52% - 2.65% 1.8% x x x x x x x x
Bronchitis Bronchitis common, 0.404% - 5.05% 1.8% - 4.29% x x x x x x x x
Acute bronchitis 0.431% - 2.02% x x
Hypertriglyceridaemia Hypertriglyceridaemia uncommon, 2.05% - 2.12% 1.08% x x x x x x x x
Blood triglycerides increased Hypertriglyceridaemia uncommon, 2.05% - 2.12% 1.08% x x x x x x x x
Hyperglycaemia Hyperglycaemia common, 0.947% - 2.56% 2.52% x x x x x x x x
Upper respiratory tract infection Upper respiratory tract infection 0% - 3.59% 0% - 4.68% x x
Nasopharyngitis Nasopharyngitis 0% - 2.46% 0% - 7.14% x x
Rhinorrhoea 0% - 2.15% 0% x
Gamma-glutamyltransferase increased Gamma-glutamyltransferase increased 0.676% - 2.84% 1.72% - 1.98% x x
Pharyngitis Pharyngitis common, 0% - 2.15% 0% - 1.08% x x x x x x x x
Sinusitis Sinusitis common, 0.901% - 1.45% 2.16% - 3.22% x x x x x x x x
Urinary tract infection Urinary tract infection common, 0% - 1.75% 0.644% - 0.721% x x
Asthenia Fatigue postmarketing — 0% - 1.41% 0.901% - 1.07% x x
Asthenia postmarketing, uncommon x x x x x x x x
Fatigue Fatigue postmarketing — 0% - 1.41% 0.901% - 1.07% x x
Pain in extremity Pain in extremity 0.47% - 1.16% 1.5% x
Pain Pain common, 0.568% - 1.54% 0.541% x x
Back pain Back pain common, 0.216% - 4.04% 1.44% - 1.72% x x x x x x x x
Cough Cough postmarketing — 0.225% - 4.3% 0% - 3.57% x x x x x x x x
Rhinitis Rhinitis common, 0% - 3.45% 0% - 1.85% x x x x x x x x
Vertigo Vertigo uncommon, 1.05% - 1.28% 0.858% x x x x x x x x
Diarrhoea Diarrhoea common, 0% - 1.86% 0% - 3.57% x x x x x x x x
Arthralgia Arthralgia 0% - 1.97% 0.721% - 1.5% x x x x x x x x
Musculoskeletal discomfort Arthralgia 0% - 1.97% 0.721% - 1.5% x x x x x x x x
Myalgia postmarketing, uncommon x x x x x x x x
Bone pain Bone pain common, 0.513% - 1.06% 0.541% x x
Alanine aminotransferase increased Alanine aminotransferase increased 0.676% - 1.7% 0.858% - 1.62% x x
Chest pain Chest pain common, 0.379% - 1.05% 0.541% - 0.858% x x x x x x x x
Blood uric acid increased Blood uric acid increased 0.386% - 1.32% 1.29% x
Hyperuricaemia uncommon, 0% - 1.77% 0.901% x x x x x x x x
Blood glucose increased Blood glucose increased 0.632% - 1.13% 2.58% x
Dyspepsia Dyspepsia common, 0.189% - 1.26% 1.08% - 1.29% x x x x x x x x
Tracheobronchitis Acute bronchitis 0.431% - 2.02% x x
Gastroenteritis Gastroenteritis common, 0% - 1.59% 0% - 0.644% x x x x x x x x
Influenza Influenza 0% - 3.77% 0% - 3.57% x x
Arthritis Arthritis common, 0% - 1.03% 0.18% x x x x x x x x
Hyperuricaemia Hyperuricaemia uncommon, 0% - 1.77% 0.901% x x x x x x x x
Injury Inflicted injury 0.513% - 1.33% 0.541% x
Insomnia Insomnia 0.189% - 1.59% 1.44% - 1.93% x x
Aspartate aminotransferase increased Aspartate aminotransferase increased 0% - 1.7% 0.858% - 1.08% x x
Angina pectoris Angina pectoris uncommon x x
Eczema Eczema uncommon x
Dermatitis Rash postmarketing, uncommon x x x x x x x x
Rash Rash postmarketing, uncommon x x x x x x x x
Hypercholesterolaemia Hypercholesterolaemia uncommon x x x x x x x
Hyperlipidaemia Hyperlipidaemia uncommon x x x
Orthostatic hypotension Orthostatic hypotension uncommon x
Palpitations Palpitations uncommon x
Shock Syncope uncommon x
Syncope Syncope uncommon x
Loss of consciousness Syncope uncommon x
Tachycardia Tachycardia uncommon x x x x x x x x
Blood potassium increased Blood potassium increased uncommon x
Toothache Toothache 0.189% - 1.54% 0.36% x
Oedema peripheral Oedema peripheral common, 0.379% - 1.19% 0.721% - 1.29% x x x x x x x x
Blood creatine phosphokinase increased Creatine phosphokinase increased 0.379% - 1.59% 0.721% x x x x x x x
Spinal disorder Spinal disorder 0.47% - 0.901% 1.5% x
Spondyloarthropathy Spinal disorder 0.47% - 0.901% 1.5% x
Nausea Nausea postmarketing, 0.189% - 2.05% 0.858% - 0.901% x x x x x x x x
Blood potassium decreased Blood potassium decreased uncommon, 0.0702% - 1.13% 0% x
Anxiety Anxiety 0.171% - 1.03% 0.36% - 1.07% x x
Gout Gout 0.353% - 1.03% 0.18% x
Erectile dysfunction Erectile dysfunction 0.353% - 2.05% 0% x
Viral infection Viral infection 0.171% - 0.421% 1.07% x
Hyperbilirubinaemia Hyperbilirubinaemia 0% - 0.883% 0.36% x
Alopecia Alopecia postmarketing x x x x x x x x
Anaphylactic shock Anaphylactic shock postmarketing x x x x x x
Angioedema Angioedema postmarketing x x x x x x x x
Hyperkalaemia Hyperkalaemia postmarketing, rare x x x x x x x x
Hypotension Hypotension rare, uncommon x x
Gastrointestinal disorder Unspecified disorder of intestine postmarketing x x x
Gastrointestinal disorder x x
Renal failure acute Renal failure acute postmarketing x x x x x x x x
Lethargy Lethargy postmarketing x x
Mediastinal disorder Mediastinal disorder postmarketing x x
Pruritus Pruritus postmarketing x x x x x x x x
Rhabdomyolysis Rhabdomyolysis postmarketing x x x x x x x x
Urticaria Urticaria postmarketing x x x x x x x x
Vomiting Vomiting postmarketing, 0% - 3.23% 0% x x x x x x x x
Malnutrition Malnutrition postmarketing x x x x x x x x
Malabsorption Sprue postmarketing x x x
Malaise Malaise postmarketing x x
Discomfort Malaise postmarketing x x
Feeling abnormal Malaise postmarketing x x
Ill-defined disorder Malaise postmarketing x x
Myalgia Myalgia postmarketing, uncommon x x x x x x x x
Blood creatinine increased Blood creatinine increased postmarketing, 0.641% - 0.913% 1.07% x x x x x x x x
Hepatic enzyme increased Hepatic enzyme increased postmarketing x x
Diabetes mellitus Diabetic postmarketing x
Microalbuminuria Microalbuminuria postmarketing x
Agranulocytosis Agranulocytosis x
Anaemia Anaemia x
Aplastic anaemia Aplastic anaemia x
Haemolytic anaemia Haemolytic anaemia x
Decreased appetite Anorexia x
Appetite absent x
Arrhythmia Arrhythmia x
Mental disorder Mental disorder x x
Infection Infection x x
Connective tissue disorder Connective tissue disorder x x
Constipation Constipation x
Oedema Oedema x
Eosinophilia Eosinophilia 0% 0% - 3.57% x
Toxic epidermal necrolysis Toxic epidermal necrolysis x
Body temperature increased Body temperature increased 0% - 3.23% 0% x x
Glycosuria Glycosuria x
Hyperhidrosis Hyperhidrosis 0% - 3.45% 0% x
Hypokalaemia Hypokalaemia x
Hyponatraemia Hyponatraemia x
Jaundice Jaundice x
Jaundice cholestatic Jaundice cholestatic x
Leukopenia Leukopenia x
Tubulointerstitial nephritis Nephritis interstitial x
Nervous system disorder Nervous system disorder x x
Neutropenia Neutropenia x
Pancreatitis Pancreatitis x
Pneumonia Pneumonia x
Renal failure Renal failure x
Sialoadenitis Sialoadenitis x
Sleep disorder Sleep disturbance x
Muscle spasms Muscle spasms x
Thrombocytopenia Thrombocytopenia x
Urethral disorder Urinary tract disorder x
Urinary tract disorder Urinary tract disorder x
Angiopathy Angiopathy x
Vasculitis Vasculitis x
Agitation Agitation x
Blood urea increased Blood urea increased uncommon, 0% 0% - 2.25% x x
Pancytopenia Bone marrow depression x
Photosensitivity reaction Photosensitivity reaction x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x
Xanthopsia Xanthopsia x
Cutaneous vasculitis Cutaneous vasculitis x
Viral upper respiratory tract infection Viral upper respiratory tract infection 0% 0% - 3.57% x
Electrolyte imbalance Electrolyte imbalance x
Vision blurred Vision blurred x
Epigastric discomfort Gastric irritation x
Systemic lupus erythematosus Lupus erythematosus x
Transaminases increased Transaminases increased x x x x x x
Respiratory distress Respiratory distress x
Face oedema Face oedema x x x x x x
Hypovolaemia Hypovolaemia x
Vasculitis necrotising Angiitis necrotising x
Infestation Infestation NOS x x
Laryngeal pain Pharyngolaryngeal pain 0% - 3.23% 0% - 1.85% x
Blood bilirubin increased Bilirubin value increased x x x x x x
Pseudohyperkalaemia Pseudohyperkalaemia 0% - 1.08% 0% - 7.14% x
Rhinorrhoea Rhinorrhoea 0% - 2.15% 0% x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

olmesartan

Side effects:43
Source:FDA Structured Product Label

OLMESARTAN

Side effects:43
Source:FDA Structured Product Label

OLMESARTAN

Side effects:43
Source:FDA Structured Product Label

OLMESARTAN

Side effects:45
Source:FDA Structured Product Label

OLMESARTAN

Side effects:45
Source:FDA Structured Product Label

OLMESARTAN

Side effects:47
Source:FDA Structured Product Label

OLMETEC / APPROVED

Side effects:83
Source:medicines.org.au

OLMETEC PLUS / APPROVED

Side effects:119
Source:medicines.org.au

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label